Web Analytics Made Easy - StatCounter

Trabectedin Tenders

Get complete information related to latest Trabectedin Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Trabectedin Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Trabectedin Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

corporations/Associations/Others

CTN :45477028 Due date: 06 Jul, 202606 Jul, 2026 13.71 Crore
Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1mg [159], atropine eye ointment ip 1%[319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder forreconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant fviii 250 iuwith diluent [749], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension[nrd-103], hpmc 0.3%eye drop [nrd-104], chloramphenic ol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment[nrd-123], cabazitaxel injection 60 mg [nrd-167], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mginj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisol one acetate 125 mg i.p. (each vial contains methylprednisol one acetate 125mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd-387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule[nrd-794], ulipristal 5mg tab. [nrd-808], black disinfectant fluid (phenyl) as per scheduleo grade iii [398], phenobarbitone inj ip 200mg/ml [420], piperacillin + tazobactum for injection ip 4gm+500mg[468], decitabine 50 mg inj. [nrd-207], levosalbutamol 50mcg. and ipratropium40mcg. mdi [nrd-425], glycopegylated extended half life factor viii 1000 iu

corporations/Associations/Others

CTN :44434778 Due date: 01 Jul, 202601 Jul, 2026 NA
Tender For corrigendum : supply of drugs/medicines - cyclosporine tab/cap -each tab/cap to contain: cyclosporine 50mg., 5-fluorouracil inj-each vial to contain: fluorouracil ip 250mg, cytosine arabinoside inj-each vial to contain: cytosine arabinoside 100mg, packing: 1 vial, tamoxifen tab/cap-each tab/cap to contain: tamoxifen 10mg, bleomycin inj-each vial to contain: bleomycin ip 15iu, vincristine inj-each vial to contain: vincristine ip 1mg, doxorubicin inj-each 5 ml vial to contain: doxorubicin 10mg, methotrexate tab/cap-each tab/cap to contain: methotrexate ip 2.5mg, ifosfamide inj-each vial to contain: ifosfamide 1gm, flutamide tab/cap-each tab/cap to contain: flutamide 250mg, goserelin inj-each pfs to contain: goserelin 3.6mg packing: 1 pfs, vero cell culture rabies vaccine-each dose to contain: purified vero cell culture human rabies vaccine, methotrexate inj-each vial to contain: methotrexate ip 50mg, tamoxifen tab/cap-each tab/cap to contain:tamoxifen 20mg, tetanus vaccine (adsorbed)-each 0.5 ml to contain: tetanus toxoid 5/lfs, capd bag-each bag to contain: capd bag 7.5% of lcodextrin with asymmetrical y connector packing:2 ltr bag, human albumin 20% inj-each bottle to contain: human albumin 20% packing: 100ml bottle, anastrozole tab/cap-each tab/cap to contain: anastrozole 1mg, asparaginase inj-each vial to contain: asparaginase 10000 unit, methotrexate tab/cap-each tab/cap to contain: methotrexate 7.5mg, sorafenib tab/cap-each tab/cap to contain: sorafenib tosylate 200mg, immunoglobulin-each 1 ml solution to contain: active substance (s) human plasma proteins 50 mg, igm 6 mg (12%) , iga 6 mg (12%) igg 38 mg (76%), packing:10ml vial, anti-rabies vaccine-each ml to contain: hrg (rabies immunoglobulin (human)) 150iu, packing:2ml vial/amp/pfs, mycophenolate tab/cap-each tab/cap to contain: mycophenolic acid (as sodium salt) 540mg, leucovorin inj-each vial to contain: leucovorin 50mg, lenalidomide tab/cap-each tab/cap to contain: lenalidomide 5mg, zoledronic acid inj-each vial to contain: zoledronic acid 4mg, octreotide inj-each vial to contains: octreotide 30mg long acting release packing: 1 vial, ceritinib tab/cap-each tab/ hard gelatin cap to contain: ceritinib 150mg, ruxolitinib tab/cap-each tab/cap to contains ruxolitinib 15mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 20mg, ruxolitinib tab/cap-each tab/cap contains ruxolitinib 5mg, nivolumab inj-each vial to contain: nivolumab 40mg packing: 1 vial, nivolumab inj-each vial to contain: nivolumab 100mg packing: 1 vial, crizotinib tab/cap-each hard gelatin tab/cap to contain : crizotinib 250mg, carfilzomib inj-each vial to contain: carfilzomib 60mg sterile lypholized powder packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 20 mg, afatinib tab/cap-each tab/cap to contain: afatinib 30 mg, axitinib tab/cap-each film coated tab/cap to contain: axitinib 5 mg, trabectedin inj-each vial to contain:trabectedin 1mg packing: 1 vial, afatinib tab/cap-each tab/cap to contain: afatinib 40 mg, regorafenib tab/cap-each tab/cap to contain: regorafenib 40mg, recombinant human granulocyte inj-each inj to contain: recombinant human granulocyte macrophage colony stimulating factor (r-hu-gmcsf) 500microgram, degarelix inj-each vial to contain: degarelix 80 mg packing: 1 vial, erlotinib tab/cap-each tab/cap to contain: erlotinib 150 mg, everolimus tab/cap-each tab/cap to contains: everolimus 5 mg, secukinumab inj-each 1 ml to conatin: secukinumab 150mg, sucrose 92.43mg, l- histidine / l- histidine hcl monohydrate 4.656 mg, polysorbate 80 - 0.60mg.packing: 1 vial, tenofovir alafenamide tab/cap-each tab/cap to contains: tenofovir alafenamide 25mg, meningococcal vaccine-each vial to contain: meningococcal group (a,c,y and w135)polysachharide/oligosaccharide diphtheria toxoid conjugate vaccine,0.5 ml vial/pfs, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 4mg, lenvatinib tab/cap-each tab/cap to contains: lenvatinib 10mg, ribociclib tab/cap-each film coated tab/cap

CTN :44976261 Due date: 01 Jun, 202601 Jun, 2026 NA
Tender For corrigendum : bi yearly tender rate contract for the supply of not quoted medicine tender to municipal hospitals maternity homes health centres and dispensaries - acyclovir eye ointment 3 %, brimonidine eye drop 2 mg/ ml, fluorescein strip (box of 100 strips), ketorolac tromethazine 0.5 % w/v eye drop 5ml, pilocarpine eye drop 2% w / v, voriconazole vial having lyophilized powder 30 mg for preparation of eye drop 1%, intracameral adrenaline 1:1000 ampule of 1 ml, fluconazole i.v. use 2mg/ ml (100ml bottle), linezolid 200 mg/100 ml, mannitol 10gm + glycerine 10 gm, polymer gelatine 3.5% i.v. soln 500ml+ nacl 0.85gm, ampicilin+cloxacilin 500 mg inj. vial, anti d (rho) immunoglobulin (monoclonal) 300 mcg (prefilled syringe), butorphenol 1 mg / ml ampules, cerebrolysin (iv inj / infusion), colistin 150 mg/vial, doxapram hydrochloride 20mg/ml for iv use only, fentanyl 50 mcg/ml, fentanyl patch 2.75mg/ patch, fosphenytoin 50 mg/ ml, hepatitis b immunoglobulin 200 iu, hydralazine hydrochloride 20 mg / ml, immunoglobulin 0.5 gm - iv use, immunoglobulin 2.5gm - iv use, iron dextran, isoxsuprine 5mg/ml, lignocaine 4% vial, lignocaine hcl 5% heavy for spinal anaesthesia 2 ml, nitroglycerides patch (ntg) transdermal 5 mg tts 5 25 mg, pancuronium bromide 2mg/ ml, pethidine hydrochloride 50 mg /ml, phenobarbitone 200mg/ml, phospholipid 27 mg, phospholipid 27 mg, quinine dihydrochloride i.p.300mg/1ml, tetanus immunoglobulin 250 iu, tetanus immunoglobulin 500 iu, thiocolchicoside 4 mg/ 2 ml, triamcinolone 10 mg, verapamil 5mg/2ml, crotamiton 10 % w/w, parrafin liquid emulsion i.p. 63.4% 500 ml, betamethasone 0.05% + gentamycin 0.1%, clindamycin 1% + benzoyl peroxide 5% w/v, colloidal silver ointment, dinoprostone gel 0.5 mg / syringe with catheter, hydroquinone 2 %, hydroquinone 2 % + tret inoin 0.025% + fluocinolone > 01%, ivermectin 1 % cream, kojic acid 2% + arbutin 1.5 % + octinoxate 7.5 %+ vit e acetate 1% + mulberry extract 1%, lidocaine topical 0.5% + nifedipine topical 0.3% ointment, retinoic acid 0.025%, salicylic acid 6 %, tazarotene 0.05%gel, tretinoin + clindamycin, ipratropium bromide 500 mcg + levo salbutamol 2.5 mg respules 2 .5ml, acyclovir 400 mg/5 ml, artemether 40 mg + lumefenterine 240 mg/ 5ml, carbamezapine 100 mg/ 5 ml, clarithromycin 250 mg / 5 ml, diethylcarbamazine 50 mg/ 5 ml, digoxin drops 0.05 mg / ml, erythromycin 125mg / 5 ml, etophyllin 46.50 mg + theophyllin hydrate 14 mg/ 5ml, ferrous ascorbate 30 mg/ 5 ml, linezolid 100 mg / 5 ml, mebendazole 100mg/5ml 30 ml bottle, montelukast 4 mg / 5 ml, multivitamin drop 15ml(without iron,folic acid), phenytoin 30 mg/5 ml, phenobarbitone 20 mg/ 5 ml, prednisolone 5mg/5 ml, quinine 150 mg/5 ml, racecadotril 10 mg, ranitidin 1 mg/ml, ampicilline 250mg + cloxacilline 250 mg each, clofazimine 50 mg, clofazimine 100 mg, diamino-dyphenyl sulfone (dapsone) 50, diamino-dyphenyl sulfone (dapsone) 100, diosmin 450 mg + methyl hesperidin 50 mg (flavonoid) (daflon), famciclovir 250mg, famciclovir 500mg, griseofulvin 250mg, ibuprofen 400mg film coated, ivermectin 3mg, ivermectin 6mg, levamisole 150 mg, mebendazole 100 mg 1x6, methyl dopa 250mg, methyl ergometrine 0.125 mg/tab, naproxen 275 mg, nifedipine 5mg sublingual, pentoxifylline 400 mg, polyvitamin prophylactic, probenecid 500 mg, promethazine 10 mg, quinine 100 mg, salbutamol 2mg., tamsulosin 0.2mg cap, vigabatrine 500 mg, vitamin a 50000 units, vitamin e 200 mg, inj.iohexol 350mg/ml, flupenthixol 20 mg /1 ml amp, flupenthixol 40 mg /2 ml amp, carbamazepine oral suspension 100mg / 5 ml, fluoxetine suspension 20 mg / 5 ml, haloperidol liquid 2 mg / ml, procyclidine 5 mg, zolpidem sr 6.25 mg, glibenclamide 5mg, ambroxol respules, azelastine nasal spray, concentrated ringer lactate 250 ml iv, d panthenol 2% ocularlubricant eye drop, fluticasone 50 mcg/actuation nasal spray, hydroxypropyl methyl cellulose gel (2%), inj. beractant 4ml (natural surfactant), inj. chloramphenicol 500 mg, inj. imepenem 250mg, inj. kannamycin 0.75 mg, in

corporations/Associations/Others

CTN :45087762 Due date: 19 May, 202619 May, 2026 8.46 Crore
Tender For short term e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - fluorouracil inj ip 250 mg/ 5ml [148], mercaptopurine tablets ip 50 mg [152], methotrexate tab ip 2.5 mg [154], vincristine injection ip 1 mg [159], atropine eye ointment ip 1% [319], ciprofloxacin ophthalmic ointment usp 0.3% [323], dacarbazine injection 500 mg ip [529], inj. ganciclovir sodium 500mg (lyophilized powder for reconstitution) [724], recombinant f ix 500 iu with diluent [748], 3rd generation recombinant f viii 250 iu with diluent [749], brinozolamide 1% w/v and brimonidine tartrate 0.2% w/v ophthalmic suspension [nrd-98], gatifloxacin 0.30% and prednisolone acetate 1% ophthalmic suspension [nrd-103], hpmc 0.3% eye drop [nrd-104], proparacaine 0.5% w/v eye drop usp [nrd-114], voriconazole 1 % w/v (lyophilized) 30mg eye drop [nrd-119], chloramphenicol 1%, polymyxin b sulphate (10000 units) and dexamethasone 0.1% sodium phosphate eye ointment [nrd-123], cabazitaxel injection 60 mg [nrd-167], carmustine 100 mg inj. ip [nrd-175], fludarabine phosphate injection 100mg inj. ip [nrd-237], fludarabine phosphate injection 50mg inj. ip [nrd-238], methotrexate 1000 mg inj. ip [nrd-289], inj. methylprednisolone acetate 125 mg i.p. (each vial contains methylprednisolone acetate 125 mg) [nrd-292], mitomycin 40 mg inj. ip [nrd-297], omalizumab 150 mg vial inj. [nrd-321], plerixafor 24 mg inj. [nrd-338], rasburicase 1.5 mg inj. [nrd-347], recombinant lh 75iu inj. [nrd-351], trabectedin 1 mg inj. [nrd- 387], everolimus 5mg tab./cap. [nrd-530], everolimus 10mg tab./cap. [nrd-531], eltrombopag 25mg tablet / capsule [nrd-617], eltrombopag 50mg tablet / capsule [nrd-618], nilotinib 150 mg tablet / capsule [nrd-710], nilotinib 200 mg tablet / capsule [nrd-711], regorafenib 40 mg tab. [nrd-757], tegafur 100mg and uracil 224mg capsule [nrd-794], ulipristal 5mg tab. [nrd-808], glycopegylated extended half life factor viii 1000 iu
 Loading, Please wait...

Connect us via What's Up